Evaluation of Refractive Errors and Ocular Biometric Outcomes after Intravitreal Bevacizumab for Retinopathy of Prematurity

Gunay M. , ŞEKEROĞLU M. A. , Bardak H., ÇELİK G., ESENÜLKÜ C. M. , HEKİMOĞLU E., ...Daha Fazla

STRABISMUS, cilt.24, ss.84-88, 2016 (ESCI İndekslerine Giren Dergi) identifier identifier identifier


Purpose: To assess ocular biometric outcomes following intravitreal bevacizumab (IVB) monotherapy for retinopathy of prematurity (ROP) and compare these results with those of laser photocoagulated infants and with the ones with spontaneously regressed ROP.